Tech Company Financing Transactions
Vestaron Funding Round
On 5/9/2012, Vestaron received $10.2 million in Series B investment from Michigan Accelerator Fund, Open Prairie Ventures and Pangaea Ventures.
Transaction Overview
Company Name
Announced On
5/9/2012
Transaction Type
Venture Equity
Amount
$10,200,000
Round
Series B
Investors
Proceeds Purpose
Proceeds from the Series B financing are being used for continued commercial development of Vestaron's biopesticide peptide based product, accelerated research for synthetic mimics to these peptides, and expanded agricultural biotechnology research and development of the use of Vestaron's peptide as a Bt replacement in GMO portfolios.
Company Information
Company Status
Private & Independent
Industry
Clean Tech
Mailing Address
600 Park Offices Dr. 117
Durham, NC 27709
USA
Durham, NC 27709
USA
Phone
Website
Email Address
Overview
Vestaron Corporation is developing a new generation of insecticides by employing peptides sourced from spiders -- insecticides that are ideally suited for the environmentally conscious, twenty-first century. Over 50 unique, spider-venom peptides with novel sites of action have been identified and are being exploited.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 5/9/2012: CopperEgg venture capital transaction
Next: 5/9/2012: SessionM venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. VC investment data records reported here are derived from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs